Back to top

Top Ranked Momentum Stocks to Buy for February 2nd

Read MoreHide Full Article

Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, February 2nd:

Cboe Global Markets, Inc. (CBOE - Free Report) : This options exchange operator has a Zacks Rank #2 (Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 0.6% over the last 60 days.

CBOE Holdings, Inc. Price and Consensus

Cboe Global Markets’s shares gained 9.6% over the last one month more than S&P 500’s gain of 5.5%. The company possesses a Momentum Score of B.

CBOE Holdings, Inc. Price

E*TRADE Financial Corporation (ETFC - Free Report) : This financial services company has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings rising 24.7% over the last 60 days.

E*TRADE Financial Corporation Price and Consensus

E*TRADE Financial’s shares gained 8.8% over the last one month. The company possesses a Momentum Score of A.

E*TRADE Financial Corporation Price

Diplomat Pharmacy, Inc. (DPLO - Free Report) : This independent specialty pharmacy operator has a Zacks Rank #1 (Strong Buy) and witnessed the Zacks Consensus Estimate for its current year earnings increasing 1.2% over the last 60 days.

Diplomat Pharmacy, Inc. Price and Consensus

Diplomat Pharmacy’s shares gained 36.1% over the last one month. The company possesses a Momentum Score of B.

Diplomat Pharmacy, Inc. Price

See the full list of top ranked stocks here

Learn more about the Momentum score and how it is calculated here.

Today's Stocks from Zacks' Hottest Strategies

It's hard to believe, even for us at Zacks. But while the market gained +18.8% from 2016 - Q1 2017, our top stock-picking screens have returned +157.0%, +128.0%, +97.8%, +94.7%, and +90.2% respectively.

And this outperformance has not just been a recent phenomenon. Over the years it has been remarkably consistent. From 2000 - Q1 2017, the composite yearly average gain for these strategies has beaten the market more than 11X over. Maybe even more remarkable is the fact that we're willing to share their latest stocks with you without cost or obligation.

See Them Free>>




In-Depth Zacks Research for the Tickers Above


Normally $25 each - click below to receive one report FREE:


E*TRADE Financial Corporation (ETFC) - free report >>

Diplomat Pharmacy, Inc. (DPLO) - free report >>

Cboe Global Markets, Inc. (CBOE) - free report >>


More from Zacks Zacks #1 Rank Additions

You May Like